Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
July 02, 2024 07:00 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has...
InterDigital signs license agreement with Google
July 02, 2024 04:00 ET
|
InterDigital, Inc.
InterDigital signed a new license agreement with Google to license InterDigital's cellular wireless, Wi-Fi, and HEVC video patented technologies
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
July 01, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with...
Adeia Enters into Multi-Year IP License Agreement with X Corp.
July 01, 2024 16:05 ET
|
Adeia Inc.
Adeia Enters into Multi-Year IP License Agreement with X Corp.
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA Pharma and Ensho Therapeutics
June 27, 2024 19:00 ET
|
Ensho Therapeutics
CHUO-KU, TOKYO and MORRIS PLAINS, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- EA Pharma Co., Ltd. (President, Hidenori Yabune; “EA Pharma”) and Ensho Therapeutics, Inc. (Founder, President and Chief...
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
June 25, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...
EnWave Signs New Royalty-Bearing Commercial License with Bounty Specialty Foods Inc., Sells 10kW REV™ Machinery
June 24, 2024 09:00 ET
|
EnWave Corporation
VANCOUVER, British Columbia, June 24, 2024 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a new royalty-bearing,...
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
June 24, 2024 07:30 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has...
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
June 24, 2024 03:00 ET
|
Acino International AG
Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...
Euro Sun Mining Confirms Validity of Mining Licence and Option to Extend
June 21, 2024 12:18 ET
|
Euro Sun Mining Inc.
BUCHAREST, Romania, June 21, 2024 (GLOBE NEWSWIRE) -- Following recent inquiries, Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) through its wholly owned Romanian subsidiary, SAMAX...